ムスタファ・ソラク医師は、乳癌、精巣癌、卵巣癌、肺癌、頭頸部癌、および消化器腫瘍を専門とする腫瘍内科医です。ハジェッテペ大学医学部を卒業後、シシリ・エトファル・イスタンブール研修研究病院で研修医課程を修了し、その後ハジェッテペ大学腫瘍研究所でフェローシップ研修を行いました。
ソラク医師は数多くの複雑な腫瘍症例を担当してまいりました。テキサス大学MDアンダーソンがんセンターをはじめとする主要施設において、臨床腫瘍学の発展に貢献しました。また、チョルムのヒッティト大学附属病院およびメディカルパーク病院においても診療に従事しました。その豊富な経験は、癌の治療と研究に対する深い献身を示しています。
ブレンダ・パストラーナ医師はメキシコ人の外科腫瘍専門医です。
医療経歴
Centro Medico Nacional 20 de Noviembre Issste、2020年より外科腫瘍専門医。
メキシコ国立自治大学（UNAM）卒業。
メキシコ社会保障機構（Instituto Mexicano del Seguro Social）外科研修修了。2015年。
キンタナロー大学（Universidad de Quintana Roo）卒業。
Conacem認定医（2020年〜2025年）認定番号2171
Conacem認定医（2025年〜2030年）認定番号2171
SMEO（メキシコ腫瘍学会・Sociedad Mexicana de Oncología）会員。
2020年よりアナワク大学（Universidad Anahuac）医学部非常勤講師。
Education and Specialization
Work Experience
Expertise
Personal Information
Sex: Male
Born : 1968
Professional Experience
Gayrettepe Florence Nigthingale Hospital
Medical Oncology Department
Besiktas/Istanbul/Turkey (ongoing)
Education:
He became Professor (22/April /2016)
Medical Oncology
Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)
Istanbul University Oncology Institue,
Department of Medical Oncology
Medical Oncology Fellowship (December 2001-December2004)
Istanbul University, Istanbul Medical Faculty
Hemodialysis Traning (May1996-January1997)
Istanbul University ,bCerrahpasa Medical Faculty
Internal Medicine Residency (November 1991-November 1996)
Istanbul University ,bCerrahpasa Medical Faculty
Ege University Medical Faculty (1985-1991)
Professional Experience
February 1999-November 2001
Metropolitan Florence Nigthingale Hospital
American Cancer Center, Gayrettepe/İstanbul
April1997- October 1998
Bayraktar Dialysis Center
Güngören/ Istanbul
Membership
Turkish Medical Oncology Association
ENET(European Neuroendocrine Tumour Society)
ESMO
ASCO
Personal information
Title: Professor Doctor
Branch: Radiation Oncology
Work History:
1 GATA Military Medical Faculty
2 Gayrettepe Florence Nightingale Hospital
3 T.R. Demiroğlu Bilim University \ Associate Professor
4 T.R Demiroğlu Bilim University \ Professor
Medical Specialties and Subspecialties:
1 Head and Neck Cancers
2 Radiation Oncology
Priority treatments:
1 Prostate cancer
2 Conformal treatments
Special advanced health technologies:
1 Truebeam Stx Technology
2 Halcyons
Education
1991 - Istanbul University Istanbul Faculty of Medicine
1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation
Oncology Specialization Training
2023 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Associate Professor
2013 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Specialist
2008 – 2013 Private Medical Park Fatih Hospital, General Surgery Specialist - Deputy Chief Physician
2005 – 2007 Private Gelişim Hospital – General Surgery Specialist
2003 – 2005 Private Istanbul Şafak Hospital – General Surgery Specialist - Chief Physician
2002 – 2003 ISTANBUL HASEKİ EDUCATION AND RESEARCH HOSPITAL – General Surgery Clinic Assistant Physician
1998 – 2002 Ankara Education and Research Hospital – General Surgery Clinic Assistant Physician
1998 – Health Sciences University – Istanbul Haseki Health Application and Research Center – Medical Specialization
1991 – Gazi University Faculty of Medicine – Bachelor’s Degree
Certificates
IGM Diagnosis, Treatment Workshop, Granulomatous Mastitis, Kocaeli, Certificate, 07.10.2023 (National)
ibreast 51- Free Flap Reconstruction, Breast Cancer Surgery, Online, Certificate, 30.09.2023 – 30.09.2023 (International)
ibreast 50- Triple Negative Breast Cancer, Breast Cancer, Online, Certificate, 02.09.2023 -02.09.2023 (International)
ibreast 49- Implant Based Reconstruction, Breast Cancer, Online, Certificate, 12.08.2023 -12.08.2023 (International)
ibreast 48- DCIS, İbreast 48- DCIS, Online, Certificate, 15.07.2023 -15.07.2023 (International)
ibreast 47- Conference Updates, Breast Cancer, Online, Certificate, 25.06.2023 -25.06.2023 (International)
ibreast 46- Margin Revisited, Breast Cancer, Online, Certificate, 10.06.2023 -10.06.2023 (International)
1. International 4. National Breast Surgery Congress, Breast Surgery, Ürgüp, Certificate, 05.05.2023 – 07.05.2023 (International)
ibreast 44- HER2 Positive Disease, Breast Cancer, Online, Certificate, 29.04.2023 -29.04.2023 (International)
St-Gallen 2023, St-Gallen Congress Summary Meeting, Istanbul, Certificate, 01.04.2023 -01.04.2023 (National)
ibreast 43- Save The Nipple, Breast Cancer, Online, Certificate, 25.03.2023 -25.03.2023 (International)
ibreast 42-Chest Wall Perforator Flap Revisited, Breast Cancer, Online, Certificate, 25.02.2023 -25.02.2023 (International)
ibreast 41- High Risk And B3 Lesions, Breast Diseases, Online, Certificate, 28.01.2023 -28.01.2023 (International)
15. New Approaches in Breast Cancer Education Meeting, Breast Cancer, Istanbul, Certificate, 07.01.2023 – 08.01.2023 (National)
Articles she wrote and took part in;
1.YILDIRIM EMİNE, BEKTAŞ SİBEL, YETİŞ FIRAT, YILDIZ EREN OZAN, ÖZDEMİR MUHAMMED, KOMUT NESLİHAN, ÇALIK MUSTAFA, ER AHMET MUZAFFER. Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer. Annali Italiani di Chirurgia, 2023
2.UZUN NEDİM, YILDIRIM EMİNE. Relationship Between Toilet Type and Hemorrhoids. Bezmialem Vakif University, 2022
3.YILDIZ EREN OZAN, YILDIRIM EMİNE, ORHUN ERDOĞAN KIVILCIM, ERYILMAZ İKLİL, YÜNLÜEL EMİR MEHMET, YETİŞ FIRAT, ULUKENT SUAT CAN. The effect of the covid 19 pandemic on the number of patients treated for acute and complex acute appendicitis. Annali Italiani di Chirurgia, 2202
4.YILDIRIM EMİNE, BEKTAŞ SİBEL, ÖZDEMİR MUHAMMED, KARAGÜLLE AHENK, ER AHMET MUZAFFER, UÇAR NEŞE. Upgrade Rates of DCIS, Intraductal Papilloma, and the Other High-risk Breast Lesions. Hamidiye Medical Journal, 2022
5.ÖZKAN GÜMÜŞKAYA PERİHAN, ALTUN ÖZGÜR, KARAKÜTÜK YÜZTAŞ NUR, ÖZSOY NESLİHAN, AYDIN TUTAK GÜLTEN, YILDIRIM EMİNE, ADAŞ MİNE, KÜÇÜK MEHMET. COVID-19 Pnömonisi Sonrası AntiHBs Değerlerindeki Değişiklikler. Journal of Contemporary Medicine, 2022;12(4),
6.KOMUT NESLİHAN, BEKTAŞ SİBEL, YILDIRIM EMİNE. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma. Annals of Diagnostic Pathology 2022 Jun;58:151933.
7.KAYADİBİ YASEMİN, UÇAR NEŞE, AKAN YEŞİM NAMDAR, KAYA MEHMET FATİH, YILDIRIM EMİNE, ALADAĞ KURT SEDA, SOYLU BOY FATMA NUR, TAŞKIN FÜSUN, İÇTEN GÜL ESEN. Magnetic resonance imaging findings associated with recurrence in idiopathic granulomatous mastitis. Clinical Imaging, 2022
8.YILDIRIM EMİNE, KEĞİN MURAT, ÖZDEMİR MUHAMMED, BEKTAŞ SİBEL, PELEN ZEKERİYA, ER AHMET MUZAFFER. Neoplasms of theAppendix; Single Institution and Ten-Year Experiences Results. Turkish Journal of Trauma and Emergency Surgery, 2022;28(3), 352-360
9.YILDIRIM EMİNE, YILDIZ EREN OZAN, ERYILMAZ İKLİL, ER AHMET MUZAFFER, BEKTAŞ SİBEL. Comparison of excised breast volume, re-excision rate and margin positivity in breast-conserving surgery in breast cancer patients using and not using neoadjuvant chemotherapy. Journal of Surgery in Medicine,2022;6
10.YILDIRIM EMİNE, BEKTAŞ SİBEL, PELEN ZEKERİYA, YANIK İREM, ER AHMET MUZAFFER, ÇENGEL FERHAT, ÖZKAN GÜMÜŞKAYA PERİHAN. Histopathological, Radiological, and Demographic Factors Predicting the Response to Neoadjuvant Therapy for Rectal Cancer. Journal of Gastrointestinal Cancer, 2022;53(1)
11.KAYADİBİ YASEMİN, KOÇAK BURAK, UÇAR NEŞE, AKAN YEŞİM NAMDAR, YILDIRIM EMİNE, BEKTAŞ SİBEL. MRI Radiomics of Breast Cancer: Machine Learning-Based Prediction of Lymphovascular Invasion Status. Academic Radiology, 2022;29(1), 126-134.
12.YILDIRIM EMİNE, UÇAR NEŞE, YETİŞ FIRAT, KAYADİBİ YASEMİN, BEKTAŞ SİBEL. Diagnostic performance of breast imaging with ultrasonography, magnetic resonance and mammography in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients. Journal of Surgery and Medicine, 2022;6(1), 43-48
13.YILDIRIM EMİNE, BEKTAŞ SİBEL, GÖKTAŞ AYDIN SABİN, ER AHMET MUZAFFER, YANIK İREM, ÖZKAN GÜMÜŞKAYA PERİHAN, YILMAZ BARBAROS UTKU, BİLİCİ AHMET, ÖNCEL MUSTAFA. Factors Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2022;85(1), 41-50.
14.YILDIRIM EMİNE, Pelen Zekeriya, KEĞİN MURAT, UÇAR NEŞE, KAYADİBİ YASEMİN, GÜNDOĞAR ÖZGECAN. Evaluation of the Reliability of Preoperative Ultrasonography and Ultrasonography-Guided Fine Needle Aspiration Biopsy in Axillary Staging in Patients With Breast Cancer. Journal of Academic Research in Medicine, 2021;11(3), 269-276.,
15. KAYADİBİ YASEMİN, UÇAR NEŞE, KAYA MEHMET FATİH, YILDIRIM EMİNE, BEKTAŞ SİBEL. Characterization of Suspicious Microcalcifications on Mammography Using 2D Shear-Wave Elastography. Ultrasound in Medicine & Biology, 2022;47(9), 2532-2542.
16.KAYADİBİ YASEMİN, TEKCAN ŞANLI DENİZ ESİN, UÇAR NEŞE, YILDIRIM EMİNE, ŞANLI AHMET NECATİ. Evaluation of the Appearance Characteristics of Suspicious Microcalcifications Detected by Ultrasonography. Journal of Academic Research in Medicine, 2022;11(2), 199-205.
17.YILDIRIM EMİNE, ÖZER HİLAL, ÖZER İLTER, KOYUNCU ADİL, YILDIRIM TİMUR. The Effects on Bacterial Translocation and Tissue Damage of Selenium Treatment in an Experimental Intestinal Ischaemia-Reperfusion Model. Turkish Journal of Trauma and Emergency Surgery, 2021;27(4), 389-394.
18.YILDIRIM EMİNE, AKBAŞ PELİN, ORHUN ERDOĞAN KIVILCIM, BEKTAŞ SİBEL, ÖZKAN GÜMÜŞKAYA PERİHAN, ER AHMET MUZAFFER, PALTURA CEKİ. The comparison of the histopathological results of the thyroid fine-needle aspiration biopsies in the 795 patients with thyroidectomy. Diagnostic Cytopathology, 2021
Prof. Thomas W Kraus is a renowned gastrointestinal doctor in Germany with over 30 years of experience and 3,000+ surgical interventions performed. He specializes in Whipple procedure management, stomach oncology and treatment of liver diseases, and is the Chief Physician in Nordwest Clinic in Francfurt am Main. Prof. Kraus is a member of several prestigious national and international medical associations, and has received numerous awards for his achievements. He has a wide range of surgical services, including laparotomy, laparoscopy, radical resection, draining of inflammatory diseases, bile ducts surgical reconstruction, bypass, stapling of the damaged bile ducts, endoscopic correction of hernias, and more.
Dr. Jaume Mora Graupera is a pediatric oncologist specializing in the treatment of neuroblastomas, gliomas, Ewing's sarcomas, and Wilms' tumors. He is the Director of the Hematology Oncology Department and Developmental Tumors Laboratory at Sant Joan De Déu - Barcelona Children’s Hospital. He received his medical degree from the University of Barcelona, went on to complete specialty training in pediatrics and fellowships in pediatric hematology oncology and molecular pathology of pediatric cancer at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in the USA. He has won multiple awards and is a member of various medical organizations.
シナン・カラアスラン医師は、アナドル・メディカルセンターの腫瘍内科医です（2014年より在籍）。乳癌、大腸癌、泌尿生殖器系腫瘍の治療を専門とし、腫瘍内科における臨床経験は2003年より積んでいます。トルコ医師会、トルコ腫瘍内科学会、トルコ肺癌学会の会員です。
患者様がカラアスラン医師を選び、信頼する理由：
イェシム（Yeşim）・ユルドゥルム教授は、Anadolu Medical Centerの腫瘍内科専門医です（2011年より在籍）。ESMO認定専門医であり、2021年より教授職を務め、80本以上の学術論文を執筆しています。Rambam（イスラエル）およびMount Vernon（英国）の主要医療機関で研修を修了。乳癌、肺癌、消化管癌、悪性黒色腫、肉腫の治療を専門とし、免疫療法および分子標的療法を実施しています。
患者がイェシム・ユルドゥルム医師を選ぶ理由：
Oncologist, Specialist in skin cancer treatment
Endocrinologist
Oncologist, Gastroenterologist
Assoc.Prof. Altan Kır is a Thoracic Surgery and Robotic Surgery specialist, as well as one of the top lung cancer doctors. He has been a thoracic surgeon at Anadolu Medical Center since 2007 and is a member of the Turkish Thoracic Surgery Society, the European Society of Thoracic Surgeons, and the Thorax Society.
Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.
Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.
アリ・ラファエル教授――テルアビブ・スラスキー医療センター（イキロフ、テルアビブ）トランスレーショナル腫瘍学部門長および臨床がん研究部門研究員。患者一人ひとりのニーズに寄り添う個別対応のアプローチが高く評価されています。
資格および患者への貢献：
腫瘍科デイホスピタルを統括し、国家ゲノム医療プロジェクトを主導。最先端の研究へのアクセスを提供しています。
主任副研究者および主任研究者として、腫瘍内mRNA投与やウイルス製剤を含むフェーズI〜IIIの多数の臨床試験に携わってきました。患者は革新的な治療法への参加機会を得られます。
米国および英国における国際的な臨床経験を有し、世界水準の治療基準と先進的なプロトコルの適用を保証しています。
国際学術団体の会員（ESMO、IASLC、ISLB、ISCORT、Israeli Medical Association）。最新の治療基準を活用し、国際的な研究に参画しています。
ICH GCP R2、Israeli MOH Guidelinesをはじめ、インフォームドコンセント、副作用管理および患者安全に関する最新課程を含む国際臨床実践基準に基づき、定期的に専門知識の更新および研修を実施しています。
ラファエル教授は、精密な治療レジメンの選択、革新的手法の導入、そして細やかな患者対応により高い信頼を得ており、治療のすべての段階において患者が安心して療養に臨める環境を提供しています。